Cargando…

Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study

BACKGROUND: Adjuvant chemotherapy is relatively underused in older patients with colon cancer in Japan, and its age-specific effects on clinical outcomes remain unclear. This study aimed to assess the effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawamura, Hidetaka, Morishima, Toshitaka, Sato, Akira, Honda, Michitaka, Miyashiro, Isao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945708/ https://www.ncbi.nlm.nih.gov/pubmed/31906959 http://dx.doi.org/10.1186/s12885-019-6508-1

Ejemplares similares

Geriatric assessment domains to predict overall survival in older cancer patients: An analysis of functional status, comorbidities, and nutritional status as prognostic factors
por: Morishima, Toshitaka, et al.
Publicado: (2020)

Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: a population-based study
por: Sato, Akira, et al.
Publicado: (2021)

Survival in non-small cell lung cancer patients with versus without prior cancer
por: Sato, Akira, et al.
Publicado: (2023)

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
por: Chen, Xin, et al.
Publicado: (2022)

Adjuvant Chemotherapy for Stage III Colon Cancer
por: Taieb, Julien, et al.
Publicado: (2020)

Patterns of staging, treatment, and mortality in gastric, colorectal, and lung cancer among older adults with and without preexisting dementia: a Japanese multicentre cohort study
por: Morishima, Toshitaka, et al.
Publicado: (2023)

Trends in clinical stage distribution and screening detection of cancer in Osaka, Japan: Stomach, colorectum, lung, breast and cervix
por: Toyoda, Yasuhiro, et al.
Publicado: (2020)

Barthel Index-based functional status as a prognostic factor in young and middle-aged adults with newly diagnosed gastric, colorectal and lung cancer: a multicentre retrospective cohort study
por: Morishima, Toshitaka, et al.
Publicado: (2021)

Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy
por: Schenone, Aaron D, et al.
Publicado: (2014)

Diagnosis and treatment of digestive cancers during COVID-19 in Japan: A Cancer Registry-based Study on the Impact of COVID-19 on Cancer Care in Osaka (CanReCO)
por: Kajiwara Saito, Mari, et al.
Publicado: (2022)

Travel patterns of patients seeking cancer care during the COVID-19 pandemic: Multi-centre cohort study in Osaka, Japan
por: Saito, Mari Kajiwara, et al.
Publicado: (2023)

Trends in survival of leukemia among children, adolescents, and young adults: A population‐based study in Osaka, Japan
por: Nakata, Kayo, et al.
Publicado: (2021)

Hospital volume and postoperative 5‐year survival for five different cancer sites: A population‐based study in Japan
por: Okawa, Sumiyo, et al.
Publicado: (2020)

Between-hospital variations in 3-year survival among patients with newly diagnosed gastric, colorectal, and lung cancer
por: Morishima, Toshitaka, et al.
Publicado: (2022)

Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer
por: Teufel, Andreas, et al.
Publicado: (2015)

Real-world evidence on adjuvant chemotherapy in older adults with stage II/III colon cancer
por: Batra, Atul, et al.
Publicado: (2020)

An age-group analysis on the efficacy of chemotherapy in older adult patients with metastatic biliary tract cancer: a Japanese cancer registry cohort study
por: Hirao, Takeru, et al.
Publicado: (2023)

Effects of laughter therapy on quality of life in patients with cancer: An open-label, randomized controlled trial
por: Morishima, Toshitaka, et al.
Publicado: (2019)

Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer
por: Lee, Mok-Won, et al.
Publicado: (2021)

Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer
por: Karim, Safiya, et al.
Publicado: (2019)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

Hospital Surgical Volume and 3-Year Mortality in Severe Prognosis Cancers: A Population-Based Study Using Cancer Registry Data
por: Taniyama, Yukari, et al.
Publicado: (2021)

Surgical volume threshold to improve 3‐year survival in designated cancer care hospitals in 2004‐2012 in Japan
por: Okawa, Sumiyo, et al.
Publicado: (2022)

Three‐year survival from diagnosis in surgically treated patients in designated and nondesignated cancer care hospitals in Japan
por: Okawa, Sumiyo, et al.
Publicado: (2021)

Minimum surgical volume to ensure 5‐year survival probability for six cancer sites in Japan
por: Okawa, Sumiyo, et al.
Publicado: (2022)

Age-Dependent Causes of Death among Patients with Breast Cancer Based on Osaka Cancer Registry and Vital Statistics in Japan
por: Nagayasu, Mayumi, et al.
Publicado: (2023)

Cause of Death among Long-Term Cancer Survivors: The NANDE Study
por: Fujii, Makoto, et al.
Publicado: (2023)

Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2019)

Expressions of 10 genes as candidate predictors of recurrence in stage III colon cancer patients receiving adjuvant oxaliplatin-based chemotherapy
por: Kumamoto, Kensuke, et al.
Publicado: (2019)

Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer
por: Liu, Qi, et al.
Publicado: (2019)

Oncologic outcomes of early adjuvant chemotherapy initiation in patients with stage III colon cancer
por: Jeong, Woon Kyung, et al.
Publicado: (2015)

Shortening adjuvant chemotherapy in stage III colon cancer: are we ready for a change?
por: Roda, Desamparados, et al.
Publicado: (2018)

Early discontinuation and dose reduction of adjuvant chemotherapy in stage III colon cancer patients
por: Boakye, Daniel, et al.
Publicado: (2021)

Survival benefit with adjuvant chemotherapy in stage III microsatellite-high/deficient mismatch repair colon cancer: a systematic review and meta-analysis
por: Tomasello, Gianluca, et al.
Publicado: (2022)

Increase in incidental detection of thyroid cancer in Osaka, Japan
por: Toyoda, Yasuhiro, et al.
Publicado: (2018)

Long‐term trends in sex difference in bladder cancer survival 1975‐2009: A population‐based study in Osaka, Japan
por: Aoe, Jo, et al.
Publicado: (2020)

Fifteen‐year survival and conditional survival of women with breast cancer in Osaka, Japan: A population‐based study
por: Kato, Mizuki, et al.
Publicado: (2023)

Prognostic impact of the presence or absence of prior cancer in patients with cancer using cure models: A population‐based study
por: Kudo, Haruka, et al.
Publicado: (2023)

Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer
por: Lee, Kil-yong, et al.
Publicado: (2019)

Benefit of Uracil–Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer
por: Chen, Po-Huang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9khmmkikot786mtl2l8itq8u7d